SCNI

#5158
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.5914 USD
-0.10%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.5901
0.5914
Year Range
0.5500
1.0499
Daily Change
-0.10%
Monthly Change
-16.82%
6 month change
-21.79%
Year Change
-21.79%
Previous Close
0.5920
Open
0.5901
Bid
Ask
Low
0.5901
High
0.5914
Volume
2
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

News